Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-19

Clinical Trial Update: Myopia Control: a Comparison Study Between Atropine and MiSight [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing atropine eye drops and MiSight contact lenses for myopia control; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine (atropine)
  • MiSight

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Myopia | Phase 2 | Status: RECRUITING